Post-translational histone modification in ocular tissues of mice exposed to arsenicals
砷暴露小鼠眼组织的翻译后组蛋白修饰
基本信息
- 批准号:10175917
- 负责人:
- 金额:$ 12.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In this administrative supplement, we propose to expand animal models of ocular diseases and include a model
of ocular tissue damage caused by exposure to vesicant chemicals. In particular, we will focus on post-
translational histone modifications resulted from exposure to the blister agent Lewisite that is one of the most
powerful arsenic-based chemical warfare agents, exposure to which damages the human body by both systemic
tissue injury (e.g., to the lungs) and local injury (e.g., to the surface of the eye). LEW easily penetrates clothing
and personal protective equipment (PPE), making the exposed human population particular susceptible causing
acute skin, kidney and lung injuries. Therefore, we hypothesize that mice exposed to LEW either through
subcutaneous absorption, inhalation, or direct eye contact experience ocular tissue damage through the
mechanism of bromodomain 4 (BRD4)-mediated histone hyperacetylation and pro-inflammatory response, and
the development of arsenical prototypes accurately mimicking the LEW-induced molecular pathogenesis of the
eye will significantly facilitate the development of new counteractive measures. In aim #1, we propose to
investigate whether the cutaneous exposure of mice to Lewisite triggers ocular tissue damage and to identify the
molecular pathways involved in ocular tissue pathobiology. In aim#2, we will determine whether direct eye
exposure to Lew in mice causes ocular tissue damage through histone modification and altered gene
expression. In aim#3, we determine whether direct eye exposure to phenylarsine oxide (PAO) in mice causes
ocular tissue damage similar to LEW-induced ocular injury. We hypothesize that PAO, a relatively less toxic
Lewisite analog, mimics LEW-induced ocular pathogenesis and, therefore, whether it could be used to
validate newly designed antidotes targeting BRD4 to fight LEW-induced damage. We will focus on corneal
and retinal tissue damage through histology and molecular assessment. These data will establish for the first
time the cellular and molecular mechanisms responsible for arsenic-mediated ocular injury. The study will also
generate a therapeutic platform and overcome current technical difficulties in testing chemical warfare agents
for eye research in a laboratory setting to validate newly designed counteract measures. My research
expertise lies in the area of retinal degeneration which complements the proposed investigation in this project.
在这种行政补充中,我们建议扩大眼部疾病的动物模型,并包括一个模型
暴露于囊泡化学物质引起的眼组织损伤。特别是,我们将专注于职位
翻译组蛋白的修饰是由于暴露于泡沫剂刘易斯石而导致的,这是最多的。
强大的基于砷的化学战剂,暴露于两种全身性的人体损害人体
组织损伤(例如,到肺部)和局部损伤(例如,眼睛表面)。 Lew轻松穿透衣服
和个人防护设备(PPE),使暴露的人口特别敏感
急性皮肤,肾脏和肺部受伤。因此,我们假设小鼠通过
皮下吸收,吸入或直接眼接触经历眼组织通过
溴结构域4(BRD4)介导的组蛋白高乙酰化和促炎反应的机理,以及
砷原型的发展准确地模仿了LEW诱导的分子发病机理
眼睛将显着促进新的反活性措施的发展。在AIM#1中,我们建议
调查小鼠对路易斯特岩的皮肤暴露是否会触发眼组织损害,并确定
参与眼组织病理生物学的分子途径。在AIM#2中,我们将确定是否直接眼睛
小鼠暴露于LEW会通过组蛋白修饰和改变基因引起眼组织损伤
表达。在AIM#3中,我们确定小鼠导致苯烷氧化物(PAO)的直接暴露
眼组织损伤类似于LEW诱导的眼部损伤。我们假设PAO是一种相对较小的毒性
路易斯特类似物,模仿LEW诱导的眼发病机理,因此,是否可以使用它
验证针对BRD4的新设计的解毒剂来对抗LEW诱导的损坏。我们将专注于角膜
通过组织学和分子评估通过视网膜组织损害。这些数据将建立第一个数据
时间,导致砷介导的眼部损伤的细胞和分子机制。这项研究也将
产生一个治疗平台并克服当前的技术困难测试化学战代理
用于实验室环境中的眼睛研究,以验证新设计的抵消措施。我的研究
专业知识在于视网膜变性领域,它补充了该项目中提议的调查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Marina Gorbatyuk的其他基金
The mechanism of vesicant-induced ocular injury
起泡剂引起的眼损伤的机制
- 批准号:1068710510687105
- 财政年份:2022
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
The mechanism of vesicant-induced ocular injury
起泡剂引起的眼损伤的机制
- 批准号:1050621510506215
- 财政年份:2022
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
Molecular mechanisms of translational control in mice with inherited retinal degeneration
遗传性视网膜变性小鼠翻译控制的分子机制
- 批准号:1009144110091441
- 财政年份:2018
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
Molecular mechanisms of translational control in mice with inherited retinal degeneration
遗传性视网膜变性小鼠翻译控制的分子机制
- 批准号:1036045410360454
- 财政年份:2018
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
Unfolded Protein Response as a Therapeutic Target for ADRP Animal Models
未折叠蛋白反应作为 ADRP 动物模型的治疗靶点
- 批准号:86768058676805
- 财政年份:2013
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
Unfolded Protein Response as a Therapeutic Target for ADRP Animal Models
未折叠蛋白反应作为 ADRP 动物模型的治疗靶点
- 批准号:85002998500299
- 财政年份:2013
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
Unfolded Protein Response as a Therapeutic Target for ADRP Animal Models
未折叠蛋白反应作为 ADRP 动物模型的治疗靶点
- 批准号:85750578575057
- 财政年份:2013
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
Unfolded Protein Response as a Therapeutic Target for ADRP Animal Models
未折叠蛋白反应作为 ADRP 动物模型的治疗靶点
- 批准号:82888478288847
- 财政年份:2010
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
Unfolded Protein Response as a Therapeutic Target for ADRP Animal Models
未折叠蛋白反应作为 ADRP 动物模型的治疗靶点
- 批准号:79488097948809
- 财政年份:2010
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
Unfolded Protein Response as a Therapeutic Target for ADRP Animal Models
未折叠蛋白反应作为 ADRP 动物模型的治疗靶点
- 批准号:81452238145223
- 财政年份:2010
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
I-TRANSFER Improving TRansitions ANd outcomeS oF sEpsis suRvivors
I-TRANSFER 改善脓毒症幸存者的转变和结果
- 批准号:1082487810824878
- 财政年份:2023
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
Practical Approaches to Care in Emergency Syncope (PACES)
紧急晕厥的实用护理方法 (PACES)
- 批准号:1085419310854193
- 财政年份:2023
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:1085013510850135
- 财政年份:2023
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
Developing a culturally adapted implementation program for teleophthalmology use in Latinx communities
制定适合拉丁裔社区远程眼科使用的文化适应实施计划
- 批准号:1077183710771837
- 财政年份:2023
- 资助金额:$ 12.45万$ 12.45万
- 项目类别:
COG NCTN Network Group Operations Center - Year 10 Administrative Supplements
COG NCTN 网络集团运营中心 - 10 年级行政补充资料
- 批准号:1088803610888036
- 财政年份:2023
- 资助金额:$ 12.45万$ 12.45万
- 项目类别: